All stock lists
IGC Pharma, Inc. (New York Stock Exchange Arca:IGC)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.25+0.00 (+0.45%)
Insider Score
––Not scored
IGC Insider Score
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
IGC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 265.00 K | 317.00 K | 350.00 K | 191.00 K | 328.00 K | 330.00 K |
| Revenue Growth (YoY) | -19.21 % | -3.94 % | 36.19 % | -53.64 % | 20.59 % | 11.86 % |
| Cost of Revenue | 217.00 K | 262.00 K | 306.00 K | 92.00 K | 174.00 K | 176.00 K |
| Gross Profit | 48.00 K | 55.00 K | 44.00 K | 99.00 K | 154.00 K | 154.00 K |
| SG&A Expense | 1.44 M | 1.24 M | 1.50 M | 1.41 M | 1.21 M | 569.00 K |
| R&D Expense | 1.39 M | 1.27 M | 1.48 M | 1.59 M | 851.00 K | 997.00 K |
| Operating Expenses | 2.83 M | 2.51 M | 2.98 M | 3.00 M | 2.06 M | 1.57 M |
| Operating Income | -2.78 M | -2.46 M | -2.94 M | -2.90 M | -1.91 M | -1.41 M |
| Pretax Income | -2.94 M | -2.40 M | -726.00 K | -1.82 M | -1.60 M | -1.20 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.94 M | -2.40 M | -726.00 K | -1.82 M | -1.60 M | -1.20 M |
| EPS (Basic) | -0.03 | -0.03 | -0.01 | -0.02 | -0.02 | -0.02 |
| EPS (Diluted) | -0.03 | -0.03 | -0.01 | -0.02 | -0.02 | -0.02 |
| Shares Outstanding | 100.33 M | 95.04 M | 95.04 M | 90.46 M | 83.03 M | 76.52 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.